Bogdan Vlacho
Overview
Explore the profile of Bogdan Vlacho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
225
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Manzini E, Vlacho B, Franch-Nadal J, Escudero J, Genova A, Reixach E, et al.
Annu Int Conf IEEE Eng Med Biol Soc
. 2025 Mar;
2024:1-4.
PMID: 40039371
The increasing availability of Electronic Health Records (EHRs) and the continuous developments and improvements of deep learning (DL) predictive models are shifting the health care process from a paradigm centered...
2.
Incidence of Diabetic Retinopathy in Individuals with Type 2 Diabetes: A Study Using Real-World Data
Hernandez-Teixido C, Barrot de la Puente J, Miravet Jimenez S, Fernandez-Camins B, Mauricio D, Romero Aroca P, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685542
: This study aimed to assess the incidence of diabetic retinopathy (DR) in patients with type 2 diabetes (T2DM) treated in primary-care settings in Catalonia, Spain, and identify key risk...
3.
Antentas M, Rojo-Lopez M, Vendrell P, Granado-Casas M, Genua I, Fernandez-Camins B, et al.
Nutrients
. 2024 Dec;
16(23).
PMID: 39683571
Background: The impact of dietary niacin on metabolic dysfunction-associated steatotic liver disease (MASLD) is elusive. This sub-study aimed to investigate the relationship between dietary niacin intake and the presence of...
4.
Fernandez-Camins B, Vlacho B, Canudas A, Ortega M, Granado-Casas M, Perera-Lluna A, et al.
BMJ Open
. 2024 Dec;
14(12):e083825.
PMID: 39675821
Introduction: Type 2 diabetes mellitus (T2DM) is a highly heterogeneous and complex metabolic disease harbouring different metabolic characteristics. Adequate characterisation of subjects is essential to allow the implementation of precision...
5.
Ortega E, Genua I, Mata-Cases M, Roque M, Vlacho B, Real Gatius J, et al.
Front Cardiovasc Med
. 2024 Oct;
11:1403363.
PMID: 39355347
Background: Cardiovascular (CV) diseases are the most common cause of death worldwide. This study aimed to investigate the incidence and type of first CV event in a broad cohort of...
6.
Vlacho B, Bundo M, Llussa J, Real J, Mata-Cases M, Cos X, et al.
Cardiovasc Diabetol
. 2024 Jun;
23(1):209.
PMID: 38898525
Background: To evaluate the association between diabetic foot disease (DFD) and the incidence of fatal and non-fatal events in individuals with type 2 diabetes (T2DM) from primary-care settings. Methods: We...
7.
Jimenez A, Vlacho B, Mata-Cases M, Real J, Mauricio D, Franch-Nadal J, et al.
Front Endocrinol (Lausanne)
. 2024 Jun;
15:1344007.
PMID: 38828412
Aims: We aimed to describe and compare the incidence of the first cardiovascular event and its major subtypes, coronary heart disease (CHD), cerebrovascular disease, heart failure (HF), or peripheral artery...
8.
Vlacho B, Mollo Iniesta A, Gratacos M, Mata-Cases M, Rubinat E, Berenguera A, et al.
Prim Care Diabetes
. 2024 May;
18(4):402-408.
PMID: 38782704
Aim: We aimed to evaluate the impact of a multicomponent healthcare intervention, primarily designed to improve glycemic control, on blood pressure and lipids in individuals with poorly controlled type 2...
9.
Vlacho B, Fernandez-Camins B, Canudas-Ventura A, Rodriguez A, Mollo A, Cos Claramunt F, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541770
Our study aimed to evaluate the performance of primary healthcare physicians (PCPs) in managing glycemia, lipids, and blood pressure in people with type 2 diabetes mellitus (T2DM) in Catalonia, Spain....
10.
Ramirez-Morros A, Franch-Nadal J, Real J, Miro-Catalina Q, Bundo M, Vlacho B, et al.
Front Endocrinol (Lausanne)
. 2024 Feb;
15:1339879.
PMID: 38390201
Introduction: Women with type 2 diabetes mellitus (T2DM) face a greater risk of cardiovascular disease (CVD) and encounter challenges in managing cardiovascular risk factors (CVRF); however, limited data are available...